SPCC622.04 Antibody

What is SPCC622.04 and what cellular functions is it associated with?

SPCC622.04 is a systematic identifier for a gene in the fission yeast Schizosaccharomyces pombe genome. While specific information about SPCC622.04 is limited in the provided search results, similar S. pombe genes follow a standard naming convention where "SPCC" indicates chromosome III location. Based on patterns observed with other S. pombe genes, SPCC622.04 likely functions within cellular networks related to protein degradation or gene expression regulation, possibly in the ubiquitin-proteasome system similar to other identified genes in the S. pombe genome .

To determine its precise function, researchers typically employ multiple experimental approaches, including genetic interaction mapping, co-immunoprecipitation with known interacting partners, and phenotypic analysis of deletion mutants. Systematic studies like Yeast Augmented Network Analysis (YANA) provide valuable frameworks for characterizing gene functions through network-based approaches .

How should antibody validation be performed specifically for SPCC622.04?

Proper validation of antibodies against S. pombe proteins requires multiple complementary approaches. For SPCC622.04 antibody validation:

• Specificity testing: Compare Western blot signals between wild-type strains and strains with SPCC622.04 deletion or epitope-tagged versions.

• Epitope-tagged controls: Generate strains with HA or GFP-tagged SPCC622.04 for parallel detection with both anti-tag antibodies and the specific SPCC622.04 antibody.

• Immunoprecipitation validation: Perform IP-Western experiments similar to those described for Pof1-GFP and Zip1-HA interactions . Specifically, immunoprecipitate with anti-SPCC622.04 antibody and probe with antibodies against predicted interaction partners.

• Cross-reactivity assessment: Test antibody reactivity against closely related proteins, particularly if SPCC622.04 belongs to a protein family with structural similarities.

The methodological approach should mirror established protocols, such as those used for validating antibodies against Pof1 in S. pombe, where both Western blotting and immunoprecipitation techniques were employed to confirm specificity .

What are the optimal fixation and permeabilization conditions for immunofluorescence microscopy using SPCC622.04 antibody?

For effective immunofluorescence using antibodies against S. pombe proteins, optimization of fixation and permeabilization is crucial:

• Primary fixation: Test both formaldehyde (3.7% for 30 minutes) and methanol fixation (-20°C for 6 minutes) methods, as protein epitope accessibility can vary significantly between these approaches. For nuclear or chromatin-associated proteins like transcription factors, formaldehyde fixation typically preserves nuclear architecture better.

• Permeabilization optimization: Use a range of Triton X-100 concentrations (0.1-1%) or test alternative detergents like NP-40 (0.5%) if initial results show poor signal intensity.

• Antigen retrieval: For certain protein epitopes, mild heat treatment (65°C) in citrate buffer (pH 6.0) can enhance epitope accessibility without disrupting cellular structures.

• Blocking conditions: Implement systematic testing of blocking reagents (BSA vs. normal serum) and concentrations (1-5%) to minimize background without compromising specific signal.

• Signal amplification: For proteins with low abundance, similar to some of the S. pombe proteins analyzed in genetic interaction studies, consider signal amplification using tyramide signal amplification or similar techniques .

The optimal conditions should be determined empirically through parallel processing of positive control samples (epitope-tagged strains) and negative controls (deletion mutants).

How should experimental conditions be optimized for detecting protein-protein interactions involving SPCC622.04?

Based on methodologies used for studying protein interactions in S. pombe:

• Co-immunoprecipitation protocol development:

  • Extract preparation: Use a FastPrep bead beater system for cell lysis under non-denaturing conditions, similar to methods employed for other S. pombe protein interaction studies .

  • Buffer optimization: Test multiple buffer compositions varying salt concentration (100-300 mM NaCl), detergent type (Triton X-100, NP-40), and additives like glycerol (5-10%) to stabilize protein complexes.

  • Cross-linking consideration: For transient interactions, implement mild cross-linking with DSP (dithiobis[succinimidylpropionate]) at 0.5-2 mM prior to lysis.

• Detection strategies:

  • For endogenous protein detection: Use the validated SPCC622.04 antibody alongside antibodies against predicted interaction partners.

  • For tagged protein systems: Implement epitope tagging similar to the Pof1-GFP and Zip1-HA system described in the literature, where both proteins could be immunoprecipitated and co-precipitated proteins detected .

• Controls and validation:

  • Include stringent negative controls using strains lacking the target protein.

  • Validate interactions through reverse immunoprecipitation experiments.

  • Confirm biological relevance through genetic interaction analysis as demonstrated in YANA methodology .

The experimental design should incorporate lessons from successful protein interaction studies in S. pombe, such as those that identified the interaction between Pof1 and Zip1 in the context of the SCF ubiquitin ligase complex .

How do you interpret conflicting Western blot results when using SPCC622.04 antibody?

When facing inconsistent Western blot results with SPCC622.04 antibody:

• Systematic troubleshooting approach:

  • Evaluate protein extraction methods: Compare mechanical disruption (bead beating) with enzymatic cell wall digestion to ensure complete protein extraction.

  • Assess buffer compatibility: Test multiple lysis buffer formulations, paying particular attention to protease inhibitor cocktail composition.

  • Optimize Western blot conditions: Systematically vary blocking agents, antibody dilutions, incubation times, and wash stringency.

• Post-translational modification analysis:

  • As observed with Zip1 protein in S. pombe, which showed multiple bands due to phosphorylation , SPCC622.04 may exist in multiple modified forms.

  • Perform phosphatase treatment of protein samples as described for Zip1-HA, where λ-phosphatase was used to confirm phosphorylation status .

  • Consider other modifications by testing with specific inhibitors (deubiquitinase inhibitors, SUMO protease inhibitors) during sample preparation.

• Quantitative analysis framework:

  • Implement densitometric analysis as described for Zip1-HA quantification .

  • Use appropriate normalization controls (Cdc2 or actin) consistent with those employed in published studies .

  • When multiple bands are present, track and quantify each band separately, as shown in the analysis of Zip1-HA bands in pof1-6 mutants .

This methodological approach enables proper interpretation of complex Western blot patterns and helps distinguish technical artifacts from biologically meaningful results.

What statistical approaches are recommended for analyzing genetic interaction data involving SPCC622.04?

Based on methodologies employed in yeast genetic interaction studies:

• Statistical framework for synthetic genetic array (SGA) analysis:

  • Implement normalized colony size quantification using software like ScreenMill as described in YANA methodology .

  • Apply appropriate statistical thresholds (P≤0.05) for identifying significant genetic interactions .

  • Use replicate exclusion methods to eliminate technical outliers from quadruplicate measurements.

• Network analysis approaches:

  • Construct interaction networks using tools like String (www.string-db.org) with high confidence thresholds (0.900) for protein-protein interactions .

  • Extend primary networks by adding first-degree neighbors to identify related functional modules.

  • Identify "orphan" hits and connect them through nearest neighbor analysis.

• Orthology mapping for translational relevance:

  • Utilize multiple orthology databases (PomBase, OrthoMCL, InParanoid8, Homologene) to identify human orthologs of interacting genes .

  • Apply statistical enrichment analyses for Gene Ontology terms and pathway membership.

  • Prioritize interactions with known disease relevance through structured literature mining.

This comprehensive statistical approach facilitates robust interpretation of genetic interaction data and enables translation to human disease contexts, as demonstrated in the YANA study methodology .

What are the most common causes of high background when using SPCC622.04 antibody in immunofluorescence?

High background in immunofluorescence experiments with S. pombe antibodies typically stems from several factors:

• Antibody-specific factors:

  • Non-specific binding: Implement additional blocking steps using 5% normal serum from the same species as secondary antibody.

  • Concentration optimization: Perform systematic titration of primary antibody (1:100 to 1:5000) to determine optimal signal-to-noise ratio.

  • Cross-reactivity: Pre-adsorb antibody against fixed cells from strains lacking the target protein.

• Sample preparation considerations:

  • Autofluorescence: Incorporate quenching steps using sodium borohydride (1 mg/ml) for 5 minutes prior to antibody incubation.

  • Cell wall interference: Optimize enzymatic digestion of cell wall using combinations of lyticase, zymolyase, or glucanases.

  • Fixation artifacts: Compare different fixation protocols, as excessive crosslinking can increase background through non-specific antibody trapping.

• Protocol modifications:

  • Wash buffer optimization: Increase detergent concentration (0.1-0.3% Triton X-100) in wash buffers.

  • Extended washing: Implement additional and longer wash steps (minimum 5 washes of 10 minutes each).

  • Secondary antibody selection: Test multiple secondary antibodies from different manufacturers and species.

This systematic troubleshooting approach follows established principles for optimizing immunostaining in yeast cells, addressing both technical and biological sources of background.

How can epitope masking issues be resolved when SPCC622.04 antibody fails to detect the protein in certain experimental conditions?

Epitope masking, a common challenge with yeast protein antibodies, can be addressed through:

• Protein extraction optimization:

  • Denaturing conditions: Test increasingly stringent denaturation conditions (1-8M urea or 0.1-2% SDS) during sample preparation.

  • Reducing agent variation: Compare standard DTT (5-100mM) with alternative reducing agents like TCEP or β-mercaptoethanol.

  • Heat treatment protocol: Evaluate multiple heating regimens (65°C for 20 minutes vs. 95°C for 5 minutes) to balance epitope exposure against protein aggregation.

• Epitope accessibility enhancement:

  • Enzymatic treatments: Implement limited proteolysis with trypsin or chymotrypsin to expose internal epitopes.

  • Protein complex dissociation: Add competitive peptides corresponding to interaction domains to disrupt protein-protein interactions that might mask epitopes.

  • Buffer composition adjustment: Vary salt concentration and pH to disrupt ionic interactions that might contribute to epitope masking.

• Alternative detection strategies:

  • Epitope tagging: Generate strains with terminally tagged SPCC622.04 (HA, FLAG, or GFP) positioned away from functional domains.

  • Multiple antibody approach: Use alternative antibodies raised against different regions of SPCC622.04.

  • Indirect detection: Identify and detect known interacting partners as proxies for SPCC622.04 presence.

These methodological approaches are designed to systematically address epitope masking issues common in the analysis of yeast proteins, particularly those involved in complex formation or subject to post-translational modifications.

How can the SPCC622.04 antibody be optimally employed in chromatin immunoprecipitation (ChIP) experiments?

For effective ChIP experiments with SPCC622.04 antibody:

• Crosslinking optimization:

  • Formaldehyde concentration: Test a range from 0.5% to 3% for 5-20 minutes to balance chromatin crosslinking with epitope preservation.

  • Dual crosslinking approach: Consider implementing DSG (disuccinimidyl glutarate) pre-treatment (2mM for 45 minutes) before formaldehyde for proteins with indirect DNA association.

  • Quenching conditions: Optimize glycine concentration (125-250mM) and quenching time to ensure complete reaction termination.

• Chromatin preparation protocol:

  • Sonication parameters: Systematically optimize sonication conditions (amplitude, pulse duration, cycle number) to achieve 200-500bp DNA fragments.

  • Enzymatic fragmentation alternative: Consider MNase digestion optimization if sonication yields inconsistent results.

  • Quality control implementation: Verify fragment size distribution by agarose gel electrophoresis prior to immunoprecipitation.

• Immunoprecipitation conditions:

  • Antibody amount titration: Test multiple antibody quantities (1-10μg per reaction) to determine optimal enrichment.

  • Bead type comparison: Evaluate protein A/G magnetic beads against agarose beads for maximal recovery with minimal background.

  • Pre-clearing optimization: Implement extended pre-clearing steps (1-4 hours) with beads alone to reduce non-specific binding.

• Controls and validation:

  • Input normalization: Process multiple input percentages (1%, 5%, 10%) to ensure accurate quantification.

  • Negative controls: Include IP with non-specific IgG and samples from strains lacking SPCC622.04.

  • Positive controls: Target known DNA regions bound by transcription factors with established ChIP protocols, such as regions bound by Zip1 .

This comprehensive ChIP methodology integrates principles from successful chromatin immunoprecipitation studies in yeast and addresses specific considerations for nuclear proteins in S. pombe.

What approaches are recommended for mapping the protein interaction network of SPCC622.04 in different cellular conditions?

To comprehensively map SPCC622.04 interaction networks:

• Complementary interaction identification methods:

  • Immunoprecipitation-mass spectrometry (IP-MS): Optimize SPCC622.04 antibody immunoprecipitation followed by mass spectrometry analysis of co-precipitated proteins.

  • Proximity-based labeling: Implement BioID or TurboID fusion constructs with SPCC622.04 to identify proximal proteins in living cells.

  • Yeast two-hybrid screening: Develop bait constructs with full-length and domain-specific fragments of SPCC622.04 for systematic interaction screening.

• Condition-specific interaction mapping:

  • Stress response profiling: Compare interaction networks under normal growth, nutrient limitation, oxidative stress, and temperature shifts.

  • Cell cycle phase analysis: Synchronize cells using methods like centrifugal elutriation or chemical block-release and analyze phase-specific interactions.

  • Genetic background variation: Profile interactions in wild-type versus mutant backgrounds with altered cellular pathways.

• Network analysis framework:

  • Hierarchical clustering: Group interactors based on condition-specific appearance/disappearance patterns.

  • Interaction strength quantification: Implement SILAC or TMT labeling for quantitative assessment of interaction dynamics.

  • Network visualization: Utilize tools similar to String database implementation described in YANA methodology .

• Validation strategies:

  • Reciprocal Co-IP experiments: Confirm key interactions through reverse immunoprecipitation experiments.

  • Functional genetic analysis: Test genetic interactions between SPCC622.04 and genes encoding interacting proteins using synthetic genetic array methodology .

  • Co-localization studies: Perform dual labeling immunofluorescence or live-cell imaging with fluorescently tagged proteins.

This systematic approach draws from successful protein interaction studies in yeast and incorporates methodologies from both targeted (Co-IP) and unbiased (IP-MS, BioID) approaches to generate comprehensive interaction networks under various cellular conditions.

What are the most effective methods for generating SPCC622.04 deletion or conditional mutants?

For generating and analyzing SPCC622.04 mutants:

• Complete gene deletion strategies:

  • PCR-based targeting: Implement PCR-mediated gene targeting using antibiotic resistance cassettes (G418, nourseothricin) with 80-100bp homology arms.

  • Target verification: Confirm deletions through multiple PCR reactions with primers internal and external to the deleted region, similar to validation methods described for cul3, pub1, and gsk3 deletions .

  • Viability assessment: If deletion proves lethal, construct heterozygous diploid strains to maintain the deletion allele.

• Conditional expression systems:

  • Thiamine-repressible nmt1 promoter system: Generate strains with SPCC622.04 under nmt1 promoter control, allowing for regulated expression through thiamine addition (15 μM) or removal .

  • Temperature-sensitive alleles: Create temperature-sensitive mutations through error-prone PCR or site-directed mutagenesis targeting conserved residues, following approaches used for generating pof1-6 and pof1-12 alleles .

  • Auxin-inducible degron system: Implement AID tagging of SPCC622.04 for rapid protein depletion upon auxin addition.

• Phenotypic analysis framework:

  • Growth curve analysis: Perform automated growth measurements using plate readers similar to methodology described for other S. pombe mutants .

  • Cell cycle phenotyping: Analyze cell morphology and DNA content through microscopy and flow cytometry, as performed for pof1-6 mutants .

  • Stress response profiling: Systematically test sensitivity to various stressors (temperature, oxidative agents, DNA damaging agents).

This comprehensive approach to genetic manipulation integrates established methodologies for S. pombe gene targeting and phenotypic characterization, enabling detailed functional analysis of SPCC622.04.

How should genetic interaction experiments involving SPCC622.04 be designed and analyzed?

Based on established genetic interaction methodologies in S. pombe:

• Experimental design considerations:

  • Query strain construction: Generate SPCC622.04 mutant strains (deletion, conditional, or hypomorphic alleles) with appropriate selectable markers.

  • Array selection: Choose deletion libraries based on pathway relevance or implement genome-wide arrays for unbiased screening.

  • Mating and selection protocol: Follow established protocols for germination on selective media containing appropriate antibiotics, similar to YANA methodology using G418 selection .

  • Replication strategy: Implement quadruplicate crosses to enable robust statistical analysis.

• Interaction scoring approach:

  • Colony size quantification: Utilize automated image analysis software like ScreenMill to quantify colony size .

  • Normalization implementation: Apply appropriate normalization methods to account for plate position effects and general growth differences.

  • Statistical threshold determination: Establish significance thresholds (P≤0.05) for identifying genuine genetic interactions .

  • Interaction classification: Distinguish between synthetic lethal (SL) and synthetic sick (SS) interactions based on growth defect severity.

• Network construction and analysis:

  • Primary network mapping: Plot direct genetic interactions using network visualization tools.

  • Network extension: Add first-degree protein interaction neighbors to identify functional modules, following YANA methodology .

  • Ortholog identification: Map interactions to human orthologs using multiple databases (PomBase, OrthoMCL, InParanoid8, Homologene) .

  • Disease relevance analysis: Analyze "hits" for relevance to human diseases through literature mining, as performed in YANA .

• Validation strategies:

  • Reciprocal deletion analysis: Confirm key interactions through reverse genetic crosses.

  • Double mutant construction: Generate defined double mutants for detailed phenotypic characterization beyond colony size measurement.

  • Suppressor screening: Identify suppressor mutations that rescue phenotypes of SPCC622.04 mutants, similar to approaches used with pof1-6 suppressors .

This systematic approach to genetic interaction analysis integrates established methodologies from yeast genetics and incorporates computational analysis frameworks to extract maximum biological insight from interaction data.

How can phospho-specific antibodies against SPCC622.04 be developed and validated?

For developing phospho-specific antibodies against SPCC622.04:

• Phosphorylation site identification:

  • Bioinformatic prediction: Use tools like NetPhos, GPS, and PhosphoSitePlus to predict likely phosphorylation sites based on consensus motifs.

  • Mass spectrometry analysis: Perform phospho-proteomics on purified SPCC622.04 under various conditions to identify actual phosphorylation sites.

  • Evolutionary conservation assessment: Prioritize sites that are conserved across fungal species, suggesting functional importance.

• Antibody development strategy:

  • Peptide design: Generate phosphopeptides (10-15 residues) centered on identified phosphorylation sites with terminal cysteine for conjugation.

  • Dual immunization approach: Implement parallel immunization with phosphorylated and non-phosphorylated peptides for subsequent affinity purification.

  • Antibody purification: Perform sequential negative and positive affinity purification to isolate phospho-specific antibodies.

• Validation methodology:

  • Phosphatase treatment controls: Test antibody reactivity before and after λ-phosphatase treatment, similar to validation performed for Zip1 phosphorylation .

  • Mutant protein analysis: Generate alanine substitutions at phosphorylation sites and confirm loss of antibody recognition.

  • Kinase manipulation: Identify and manipulate upstream kinases to modulate phosphorylation state for antibody validation.

• Application optimization:

  • Western blot conditions: Determine optimal blocking agents (BSA vs. milk protein) and buffer compositions for phospho-epitope detection.

  • Immunoprecipitation protocol: Incorporate phosphatase inhibitors (10mM NaF, 1mM Na₃VO₄, 10mM β-glycerophosphate) in all buffers.

  • Signal enhancement: Implement tyramide signal amplification for detection of low-abundance phosphorylated species.

This comprehensive approach to phospho-specific antibody development incorporates lessons from successful characterization of phosphorylated yeast proteins, such as the phosphorylated forms of Zip1 identified in the pof1-6 mutant .

What are the best practices for using SPCC622.04 antibody in multiplex immunostaining experiments?

For optimal multiplex immunostaining with SPCC622.04 antibody:

• Antibody compatibility assessment:

  • Species origin evaluation: Select primary antibodies from different host species (rabbit, mouse, rat, goat) to enable simultaneous detection.

  • Isotype determination: When antibodies from the same species are required, use different isotypes (IgG1, IgG2a, IgG2b) and isotype-specific secondary antibodies.

  • Sequential staining protocol: For incompatible antibody combinations, implement sequential staining with complete elution between rounds.

• Signal separation strategies:

  • Fluorophore selection: Choose fluorophores with minimal spectral overlap (e.g., Alexa 488, Cy3, Alexa 647) for clear signal discrimination.

  • Sequential scanning: Implement sequential rather than simultaneous scanning on confocal microscopes to minimize bleed-through.

  • Linear unmixing: Apply spectral unmixing algorithms when using fluorophores with partially overlapping emission spectra.

• Protocol optimization:

  • Fixation compatibility: Ensure all target proteins are adequately preserved by the selected fixation method.

  • Blocking strategy: Use combined blocking with normal sera from all secondary antibody host species.

  • Antibody order determination: Test multiple antibody incubation sequences to identify optimal order for epitope detection.

• Controls and validation:

  • Single-stain controls: Perform parallel single-antibody staining for accurate assignment of signals.

  • Absorption controls: Pre-absorb each primary antibody with excess target antigen to confirm specificity.

  • Cross-reactivity testing: Apply each secondary antibody individually with all primary antibodies to check for non-specific binding.

This methodological approach addresses the technical challenges of multiplex immunostaining in yeast cells and provides a framework for obtaining clean, specific signals for multiple target proteins simultaneously.

How can SPCC622.04 research findings be integrated with human disease studies?

For translating SPCC622.04 research to human disease contexts:

• Orthology mapping framework:

  • Multi-database integration: Identify human orthologs using multiple orthology databases (PomBase, OrthoMCL, InParanoid8, Homologene) as described in YANA methodology .

  • Domain conservation analysis: Evaluate functional domain conservation between SPCC622.04 and human orthologs.

  • Interaction network comparison: Map yeast interaction networks to equivalent human protein networks through ortholog pairs.

• Disease association analysis:

  • Genetic variation assessment: Analyze human ortholog genes for disease-associated variants in databases like ClinVar and GWAS Catalog.

  • Expression correlation: Examine expression patterns of human orthologs in disease-relevant tissues through mining of transcriptomic datasets.

  • Pathway enrichment: Perform pathway analysis to identify disease processes where SPCC622.04 orthologs participate.

• Model system translation:

  • Complementation testing: Test if human orthologs can functionally replace SPCC622.04 in S. pombe.

  • Disease mutation modeling: Introduce equivalent mutations associated with human disease into SPCC622.04 to assess functional impact.

  • Drug response profiling: Use S. pombe as a platform for testing compounds targeting pathway components identified through SPCC622.04 studies.

• Collaborative framework development:

  • Data integration platforms: Establish databases linking yeast functional data with human disease associations.

  • Cross-species phenotype ontologies: Implement structured vocabularies for comparing phenotypes across model systems.

  • Translational research consortia: Form collaborative networks between yeast researchers and clinical investigators.

This systematic approach to translational integration follows principles established in studies like YANA , where yeast genetic interaction data was successfully mapped to human disease contexts through careful orthology analysis and network integration.

What computational tools are most effective for integrating SPCC622.04 antibody data with other -omics datasets?

For computational integration of SPCC622.04 antibody data with other -omics information:

• Data preprocessing approaches:

  • Normalization strategy selection: Implement appropriate normalization methods for each data type (antibody signals, transcriptomics, proteomics).

  • Batch effect correction: Apply ComBat or similar algorithms to remove technical variation when integrating datasets from different experiments.

  • Missing data handling: Develop imputation strategies appropriate for each data type based on data distribution patterns.

• Multi-omics integration methods:

  • Correlation network analysis: Construct networks based on correlation patterns across multiple data types.

  • Factor analysis: Apply methods like MOFA (Multi-Omics Factor Analysis) to identify latent factors explaining variation across datasets.

  • Joint clustering approaches: Implement iCluster or similar algorithms for identifying multi-omics clusters.

  • Graph-based data fusion: Develop heterogeneous networks where nodes represent different biological entities and edges represent various relationship types.

• Visualization frameworks:

  • Multi-dimensional visualization: Implement t-SNE or UMAP projections of integrated datasets.

  • Interactive network browsers: Develop Cytoscape-based tools for exploring multi-omics networks, similar to those used in YANA methodology .

  • Heatmap integration: Create linked heatmaps showing patterns across different data types.

• Biological interpretation tools:

  • Pathway enrichment: Apply gene set enrichment analysis to identify pathways represented in integrated datasets.

  • Causal modeling: Implement Bayesian networks to infer causal relationships between different data types.

  • Temporal sequence analysis: Develop methods to infer temporal ordering of events across multi-omics data.

This comprehensive computational framework enables effective integration of antibody-based data with diverse -omics datasets, facilitating systems-level understanding of SPCC622.04 function in cellular contexts.